These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 808448)

  • 1. Behavior of several one-stage prothrombin time derivative tests in the abnormal factor X (factor X Friuli) coagulation disorder.
    Girolami A; Peruffo R; Borsato N; Zucchetto M
    Haematologica; 1975 Jun; 60(2):157-67. PubMed ID: 808448
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies on the abnormal factor X (factor X Friuli) coagulation disorder. A report of another family.
    Girolami A; Lazzarin M; Scarpa R; Brunetti A
    Haematol Lat; 1970; 13(2):169-83. PubMed ID: 5504043
    [No Abstract]   [Full Text] [Related]  

  • 3. Prothrombin level and activity in the abnormal factor X (factor X Friuli) hemorrhagic disorder.
    Girolami A; Sticchi A; Brunetti A
    Thromb Diath Haemorrh; 1971; 25(1):147-56. PubMed ID: 4996074
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rapid tests for diagnosis of coagulation disturbances. Results of a clinical trial].
    Norén I; Blombäck M
    Nord Med; 1969 Oct; 82(41):1277-83. PubMed ID: 5354534
    [No Abstract]   [Full Text] [Related]  

  • 5. A "new" congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred.
    Girolami A; Molaro G; Lazzarin M; Scarpa R; Brunetti A
    Br J Haematol; 1970 Aug; 19(2):179-92. PubMed ID: 4989292
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor X Friuli coagulation disorder. Report of a newly recognized patient and some considerations on the frequency of the disease in the Friuli area.
    Girolami A; Falomo R; De Marco L; Patrassi G
    Acta Haematol; 1976; 56(1):27-38. PubMed ID: 822673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor X Friuli coagulation disorder. First report of a patient born in Friuli after the description of the disease.
    Girolami A; Carli A; Falomo R; De Marco L
    Blut; 1973 Sep; 27(3):151-8. PubMed ID: 4762001
    [No Abstract]   [Full Text] [Related]  

  • 8. A family with heterozygous factor X Friuli defect outside Friuli.
    Girolami A; Lazzarin M; Procidano M; Luzzatto G
    Blut; 1983 Mar; 46(3):149-54. PubMed ID: 6824795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal factor X (factor X Friuli) coagulation disorder. The heterozygote population. A study of 57 subjects.
    Girolami A; Brunetti A; Bareggi G; Cella G
    Acta Haematol; 1974; 51(1):40-50. PubMed ID: 4217072
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical use of a test for determination of coagulation factors II, X and VII].
    Cascino A; Cangiano C; Attili AF
    Minerva Med; 1975 Aug; 66(55):2743-9. PubMed ID: 1161171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of several tissue thromboplastins on the activation of the abnormal factor X (factor X Friuli).
    Girolami A; Lazzarin M; Molaro G
    Thromb Diath Haemorrh; 1972 Jul; 27(3):535-42. PubMed ID: 4197046
    [No Abstract]   [Full Text] [Related]  

  • 12. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.
    Angelos MG; Hamilton GC
    Emerg Med Clin North Am; 1986 Feb; 4(1):95-113. PubMed ID: 3512249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Production of various vitamin K-dependent coagulation factors by immunoadsorbent technics and their clinical application].
    Takamiya O
    Rinsho Byori; 1985 Feb; Spec No 61():119-23. PubMed ID: 3889420
    [No Abstract]   [Full Text] [Related]  

  • 14. [Moschcowitz's disease: consumption coagulopathy?].
    Muller JM; Couderc P; Kolodie L; Cordonnier D; Massot C; Schaerer R; Martin H
    Presse Med (1893); 1969 Nov; 77(51):1895-8. PubMed ID: 5392524
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coagulation tests from capillary blood. Determination of thromboplastin time, thrombin time, fibrinogen, factor II (prothrombin), factor V (accelerin) and factor X (Stuart-Prower factor) from capillary blood].
    Muntean W
    Z Kinderheilkd; 1975; 118(4):337-46. PubMed ID: 1130122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation and fibrinolysis in simian Plasmodium knowlesi malaria.
    Sucharit P; Reid HA
    Southeast Asian J Trop Med Public Health; 1973 Mar; 4(1):15-8. PubMed ID: 4198003
    [No Abstract]   [Full Text] [Related]  

  • 17. [Congenital and familial dysfibrinogenemia without hemorrhagic tendancy].
    Samama M; Soria J; Soria C; Bousser J
    Nouv Rev Fr Hematol; 1969; 9(6):817-32. PubMed ID: 4245042
    [No Abstract]   [Full Text] [Related]  

  • 18. Bleeding mechanisms with special attention to coagulation disorders.
    Clin Pediatr (Phila); 1968 Jan; 7(1):34-42. PubMed ID: 5635217
    [No Abstract]   [Full Text] [Related]  

  • 19. A modified prothrombin consumption time test (MPCT).
    Russell HT; Raymer H; Lobstein OE
    Am J Med Technol; 1968 Sep; 34(9):508-12. PubMed ID: 5693052
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood clotting diagnosis with chromogenic substrates].
    Róka L; Rasche H
    Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.